GL1X · GenesisL1 explorer

Research workbench

Dlk in complex with compound 10 (5-(1-isopropyl-5-(3-(oxetan-3-yl)-3- AZABICYCLO[3.1.0]HEXAN-6-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl) pyridin-2-amine)

Analyse Dlk in complex with compound 10 (5-(1-isopropyl-5-(3-(oxetan-3-yl)-3… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VO1
Type
protein
Length
269 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase kinase kinase 12
EC
2.7.11.25
UniProt
Q12852
Ligands
9FS
Pockets
2 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25)protein26945% helix, 16% strandQ12852

Ligands and binding sites

  • 9FS · 5-{5-[(1R,5S,6r)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]-1-(propan-2-yl)-1H-pyrazol-3-yl}-3-(trifluoromethyl)pyridin-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11190.580.85229FS
2670.380.7817empty

Compared structures

  • 5VO1 · DLK in complex with compound 10 (5-(1-isopropyl-5-(3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexa… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q12852 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase kinase kinase 12… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.